Bank of New York Mellon’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bank of New York Mellon's JUNO Position: Q1 2018 in Review

Bank of New York Mellon sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 339,112 shares — an estimated $15.5M sold.

Bank of New York Mellon first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $15.5M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

• Bank of New York Mellon reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
• Bank of New York Mellon sold 339,112 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $15.5M.
• Bank of New York Mellon first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
• Bank of New York Mellon's Juno Therapeutics, Inc. position peaked at $15.5M in Q4 2017.
• 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.